Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Farmers Insurance
Mallinckrodt
Covington
Boehringer Ingelheim
Argus Health
Federal Trade Commission
McKinsey
Baxter

Generated: August 20, 2018

DrugPatentWatch Database Preview

Metoprolol tartrate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for metoprolol tartrate and what is the scope of metoprolol tartrate patent protection?

Metoprolol tartrate is the generic ingredient in two branded drugs marketed by Novartis, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Luitpold, Mylan Asi, Sandoz Inc, Watson Labs, West-ward Pharms Int, Us Pharms Holdings I, Alembic Pharms Ltd, Apothecon, Aurobindo Pharma, Ipca Labs Ltd, Mylan, Purepac Pharm, Renata, Rubicon Res Pvt Ltd, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, and Yaopharma Co Ltd, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty-nine drug master file entries for metoprolol tartrate. Sixty-seven suppliers are listed for this compound.

Pharmacology for metoprolol tartrate

US Patents and Regulatory Information for metoprolol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 073654-003 Dec 21, 1993 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 076704-001 Jan 16, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold METOPROLOL TARTRATE metoprolol tartrate INJECTABLE;INJECTION 091307-001 Dec 29, 2010 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alembic Pharms Ltd METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 202871-002 May 28, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for metoprolol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984 ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
Cerilliant
McKinsey
Fuji
Deloitte
Federal Trade Commission
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.